#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Nephropathy Hypochromic anaemia Dementia Alzheimer's type Vulval cancer recurrent Penile cancer Peripheral T-cell lymphoma unspecified Glioblastoma Systemic sclerosis pulmonary Pouchitis Familial haemophagocytic lymphohistiocytosis Oesophageal squamous cell carcinoma stage II Pseudomyxoma peritonei White matter lesion Acute graft versus host disease in intestine Gastrooesophageal cancer More trials…

    Learn about Rare Diseases

    Glomerulonephritis membranoproliferative – Treatment Bronchopulmonary dysplasia – Life with Disease Shprintzen-Goldberg syndrome – Diagnostics Rosai-Dorfman syndrome – Life with Disease Ornithine transcarbamoylase deficiency – Trials in Disease Netherton’s syndrome – Trials in Disease Erdheim-Chester disease Pemphigoid – Diagnostics Haemophilia B with anti factor IX Pemphigoid – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    ANTIMETABOLITES Tamibarotene Diazepam Transpocart19 BENZYLPENICILLIN POTASSIUM Atacicept Leriglitazone Nacubactam Iph6501 Calcium Oxybate PRT3789 Oxytocin Tebipenem Pivoxil Hydrobromide Glimepiride Losartan OMEGA-3-ACID ETHYL ESTERS 90 Esflurbiprofen Trandolapril O15-Water BI-1607 More therapies…

    Learn about Your Condition

    Herpes virus infection BRAF gene mutation Hyperhidrosis Klinefelter's syndrome Thymic carcinoma Staphylococcal infection Leiomyosarcoma recurrent Bile duct cancer Gallbladder cancer Mucosal inflammation Glaucoma Neoplasm malignant Thromboangiitis obliterans Lichenoid keratosis Congenital pseudarthrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Small cell lung cancer extensive stage

  • Study of Ifinatamab Deruxtecan with Atezolizumab and Carboplatin for Patients with Extensive-Stage Small Cell Lung Cancer

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Atezolizumab
    • Carboplatin
    France Spain

  • Study on Maintenance Therapy with Durvalumab and Olaparib for Patients with Extensive Disease Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Durvalumab
    • Olaparib
    Germany

  • Study on Niraparib with Immunotherapy for Patients with SLFN11-Positive Extensive-Stage Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Lung neoplasm malignant
    • Small cell lung cancer
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    • Atezolizumab
    • Durvalumab
    France Germany Italy Romania Spain

  • Study on Pembrolizumab and Olaparib for Patients with Extensive-Stage Small-Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Etoposide
    Italy

  • Study on Durvalumab with Carboplatin or Cisplatin and Etoposide for First-Line Treatment in Patients with Extensive Stage Extrapulmonary Small Cell Carcinoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Small cell lung cancer extensive stage
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Durvalumab
    Italy

  • Study of MK-6070 drug combination in first-line extensive-stage small cell lung cancer patients

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • GOCATAMIG
    • Ifinatamab Deruxtecan
    • Atezolizumab
    France Germany Greece Italy Poland Spain
Previous Page
1 2 3 4 5
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!